IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system received CE Mark for the ...
Edwards Lifesciences Corporation EW recently gained CE Mark for its PASCAL Precision transcatheter valve repair system used to treat mitral and tricuspid regurgitation. The PASCAL Precision system is ...
Edwards Lifesciences has scored a CE mark for its Pascal Precision transcatheter valve repair system for the treatment of mitral and tricuspid regurgitation (MR and TR). "Delivering the Pascal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results